Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV000770622 | SCV000902073 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2016-03-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000801209 | SCV000940975 | uncertain significance | Adams-Oliver syndrome 5 | 2018-11-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). This variant has not been reported in the literature in individuals with NOTCH1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change replaces serine with leucine at codon 1651 of the NOTCH1 protein (p.Ser1651Leu). The serine residue is highly conserved and there is a large physicochemical difference between serine and leucine. |
Genome- |
RCV000801209 | SCV002553384 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271031 | SCV002553385 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |